Shanghai Shen Lian Biomedical Corporation

Shanghai Stock Exchange 688098.SS

Shanghai Shen Lian Biomedical Corporation Total Assets for the year ending December 31, 2023: USD 224.51 M

Shanghai Shen Lian Biomedical Corporation Total Assets is USD 224.51 M for the year ending December 31, 2023, a -3.47% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Shanghai Shen Lian Biomedical Corporation Total Assets for the year ending December 31, 2022 was USD 232.59 M, a -7.54% change year over year.
Shanghai Shen Lian Biomedical Corporation Total Assets for the year ending December 31, 2021 was USD 251.57 M, a 8.43% change year over year.
Shanghai Shen Lian Biomedical Corporation Total Assets for the year ending December 31, 2020 was USD 232.02 M, a 11.61% change year over year.
Shanghai Shen Lian Biomedical Corporation Total Assets for the year ending December 31, 2019 was USD 207.88 M, a 41.12% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shanghai Stock Exchange: 688098.SS

Shanghai Shen Lian Biomedical Corporation

CEO	Mr. Dongsheng Nie
IPO Date	Oct. 28, 2019
Location	China
Headquarters	No. 48 Jiangchuan East Road
Employees	380
Sector	Health Care
Industries Biotechnology Pharmaceuticals Vaccines

Description

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

Key trends

Past 5 years